The study revealed that pretreatment levels of TNF-α, IL-1β, and IL-6 were significantly higher in non-responders than in the group of patients who responded to treatment, which indicates that baseline levels of pro-inflammatory cytokines in child MDD might help to predict resistance to fluoxetine treatment. This evidence concerns the gene IL1B and major depressive disorder.